Five-year follow-up from the small, randomized REVELATION trial indicates that rates of clinical events are similar between STEMI patients initially randomized to a drug-coated balloon (DCB) or ...
In patients with in-stent restenosis (ISR) affecting two or more drug-eluting stents, treatment with a drug-coated balloon (DCB) offers better efficacy than plain old balloon angioplasty (POBA), ...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the receipt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results